Navigation Links
Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
Date:2/27/2013

countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com 

Forward-Looking Statements This press release includes statements that constitute "forward-looking statements", including with regard to the Company's future operations, its anticipated business levels, future earnings, planned activities, anticipated growth, and other expectations and targets for future periods. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, and often may be identified by the use of words such as "may", "believe", "anticipate", "expect", "plan", "estimate", "target" and variations of these words or comparable words. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: challenges, risks and costs inherent in business integrations and in achieving anticipated synergies; the effect of any changes in customer and supplier relationships and customer purchasing patterns; the ability to attract and retain key personnel; changes in third-party relationships; the impacts of competition; changes in economic and financial conditions of the Company's business; uncertainties and matters beyond the control of management; and inherent uncertainties involved in the estimates and judgments used in the preparation of financial statements, and the providing of estimates of financial measures, in accordance with GAAP and related standards or on an adjusted basis. These forward-looking statements should be considered in connection with any subsequent written or oral forward-look
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
2. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
3. Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast
4. Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors
5. Mylan Announces Pricing of Senior Notes
6. Moodys and Standard & Poors Upgrade Mylan to Investment Grade Credit Ratings
7. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
8. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
9. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
10. Mylan Launches Lithium Carbonate Extended-Release Tablets USP
11. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)... July 10, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... it has completed the sale to Galderma of all ... or held by Valeant for $1.4 billion in cash, ... which recently completed its acquisition of Galderma. ... our products to a company that is firmly committed ...
(Date:7/10/2014)... , July 10, 2014   LabStyle ... Management Solution, today announced the appointment of Professor ... member of its Board of Directors. ... and business experience to LabStyle as an entrepreneur, ... legal and corporate governance expert. He currently serves ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4
... Nile Therapeutics,Inc. (Nasdaq: NLTX ), today announced ... failure patient in its Phase IIa, multi-center, open-label,ascending ... candidate,CD-NP, a novel chimeric natriuretic peptide, in development ... The primary objective of the Phase IIa study ...
... 10 Medarex, Inc.,(Nasdaq: MEDX ) today ... in research discovery and antibody development, and the,multiple ... value.,In addition, comprehensive updates on current and future ... were presented by Medarex,s,President and CEO, Howard H. ...
Cached Medicine Technology:Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients 2Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 2Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 3Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 4Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 5Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City 6
(Date:7/11/2014)... (HealthDay News) -- Prostate cancer patients are more likely ... treatment and die sooner if they also have depression, ... more than 41,200 American men who were diagnosed with ... them through 2009. Nearly 1,900 of the patients had ... their prostate cancer was discovered. "Men with intermediate- ...
(Date:7/11/2014)... Riverside Health System became the first provider of ... late 2012 and now, in partnership with Williamsburg Landing, will ... Williamsburg and Newport News region. , Also known as life ... independent older adults who wish to remain in their homes ... continuing care services as well as control over the cost ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray ... Forecast to 2018", analyzes and studies the major ... Europe, Asia, and the Rest of the World ... growth in the past few years, mainly due ...
(Date:7/11/2014)... best available treatment for patients, from a range of ... taxpayers than the existing clinical trial process, a new ... out while he was a member of the Clinical ... at The University of Manchester,s Health eResearch Centre, published ... today (Friday 11 July) looked at the use of ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 With the ... in men seeking cosmetic surgery and hair transplant procedures, ... such an expansive range of medical tourism destinations, the ... plastic surgery costs and achieve the look they ... renowned as the top name in the medical tourism ...
Breaking Medicine News(10 mins):Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 2Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 3Health News:Riverside and Williamsburg Landing Partner to Offer First of Its Kind Service to Virginians Who Want to Age in Place 4Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 2Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 3Health News:Proteomics Market Worth $20,696.4 Million by 2018 - New Report By MarketsandMarkets 4Health News:Better use of electronic health records makes clinical trials less expensive 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 2Health News:VisitandCare.com Reports Increase in Cosmetic and Hair Transplant Procedures for Men 3
... 3 (HealthDay News) -- The brain,s so-called reward center actually ... experiences causing fear, finds a new study in mice. ... may help explain why some people are thrill-seekers. Pleasurable ... off a bridge, can trigger the production of dopamine, a ...
... discovered that a natural product isolated from a traditional Chinese ... gong teng, and used for hundreds of years to treat ... machinery in the cell. The report, published as a cover ... suggests that the natural product could be a starting ...
... By Alan Mozes HealthDay Reporter , THURSDAY, ... of your computer hour after hour may well have its ... include dry, tired eyes, blurred vision, fatigue and headaches. ... but eye experts don,t agree on whether it,s serious or ...
... School of Medicine have found that lactate, a type of ... the formation of long-term memory. These findings have important implications ... memory impairment and diabetes. The research is published in the ... The study is the first to closely evaluate the role ...
... Using recent advances in genomics, researchers have uncovered a genetic ... could help predict which patients are at risk of relapse ... or "turned on" in breast cancer, research led ... several members of the E2F family of genes, which control ...
... cancer, lung cancer, breast cancer or prostate cancer. The study ... by 25 per cent after the cancer diagnosis. , ... and an increased workload that places a strain on one,s ... diagnoses of mental illnesses such as depression. However, there was ...
Cached Medicine News:Health News:Solving a traditional Chinese medicine mystery 2Health News:Solving a traditional Chinese medicine mystery 3Health News:Computer Vision Syndrome: Fact or Fiction? 2Health News:Computer Vision Syndrome: Fact or Fiction? 3Health News:Researchers find new mechanism behind the formation and maintenance of long-term memories 2Health News:Researchers pinpoint genetic pathways involved in breast cancer 2Health News:Cancer patients' partners become ill themselves 2
Li Brand™ Surgical Hemostat. ("dissecting clamp") For NSV and other procedures....
... for applications such as vasectomy that ... ,The autoclavable handpiece with six-foot cord ... cautery electrodes, allowing the physician to ... wide variety of procedures., ,The 2201 ...
No Scalpel Vasectomy Hemostat 5 1/2" (14cm), smooth sharp point, curved, gold finger rings...
Li Brand™ Ringed Forceps. ("fixation clamp") For NSV and other procedures. Ring diameter approximately 3.5 mm. Manufactured exclusively for AMI to exacting specifications by a German company....
Medicine Products: